Investigators analyzed economic evaluations of adjuvant immunotherapy to assess cost-effectiveness outcomes, quality-adjusted life-year (QALY)/life-year (LY) gains, and methodologic approaches.

Investigators compared the interval cancer rate in AI-supported mammography screening versus standard double reading without AI.

In this phase 2a study, researchers aimed to determine whether donor fecal microbiota transplantation improved survival in mRCC patients receiving immunotherapy.

Investigators evaluated dual immune checkpoint inhibitors for safety and efficacy in patients with brain metastases from rare cancers.

In this phase 2 study, researchers explored whether fecal microbiota transplant could overcome resistance to immune checkpoint inhibition.

Although hospital-owned plans are only a sliver of the Medicare Advantage market, their enrollment continues to grow.

Investigators reviewed data from the SANO trial to assess long-term comparative effectiveness of active surveillance vs standard esophagectomy in patients with complete clinical response following ...

The National Comprehensive Cancer Network’s newly updated non-small cell lung cancer guideline adds sevabertinib as a treatment option for some patients with advanced disease, makes datopotamab ...

In this study, researchers analyzed data from national databases to determine cervical cancer incidence and mortality rates across the United States.

Investigator sought to determine whether nelfinavir mesylate plus chemoradiation and image-guided brachytherapy could improve disease-free survival for patients with stage III cervical cancer.

In this retrospective study, researchers explored mortality among women with breast cancer in states with and without Medicaid expansion.

Darzalex Faspro is a subcutaneous formulation that combines daratumumab, a CD38-directed cytolytic antibody, and hyaluronidase, an endoglycosidase.